Furthermore, the effect of both BIM and PTEN on paclitaxel resistant in ovarian cancer cells has not been thoroughly researched; particularly, the mechamism involved in their expression regulation has barely been studied in ovarian carcinoma chemoresistance. The gene discussed is BCL2L11; the disease is ovarian carcinoma.